Age-related changes and reference intervals of RANKL, OPG, and bone turnover markers in Indian women
- 4 October 2021
- journal article
- research article
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 16 (1) , 1-7
Abstract
Summary RANKL and OPG are cytokines involved in bone remodeling that makes them potential bone biomarkers. The reference interval for these cytokines, their ratio, and bone turnover markers CTX and PINP were established in Indian women, which may serve in diagnosis and management of osteoporosis. Purpose The aim of the study was to establish reference interval for RANKL, OPG, RANKL/OPG, and bone turnover markers CTX and PINP in healthy Indian women. Methods This was a cross-sectional study on 374 healthy Indian women in the age group of 20–65 years. Serum levels of total RANKL, OPG, CTX, PINP, and estradiol were determined by commercial ELISA kits. The reference intervals for these cytokines and bone turnover markers were based on the 95% centrally distributed data. Results Median RANKL (245.6 pmol/L vs. 149 pmol/L) and RANKL/OPG (38.7 vs. 20.4) were higher, while sCTX (380 ng/L vs. 551 ng/L) and OPG levels (6.1 pmol/L vs. 7.4 pmol/L) were lower in premenopausal women than those in postmenopausal women. PINP levels were comparable in both groups. Women were classified into 5 groups according to decades of age and the reference intervals for RANKL, OPG, RANKL/OPG ratio, and CTX and PINP in each group were reported. Conclusion We reported menopausal status–based and age-related reference intervals for serum RANKL, OPG, RANKL/OPG ratio, and CTX and PINP in healthy Indian women.Keywords
Funding Information
- ICMR-NIRRH
This publication has 34 references indexed in Scilit:
- Age-related reference intervals for bone turnover markers from an Australian reference populationBone, 2013
- Bone turnover markers: use in osteoporosisNature Reviews Rheumatology, 2012
- Establishing a reference range for bone turnover markers in young, healthy womenBone, 2008
- Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of OsteoporosisCritical Reviews in Clinical Laboratory Sciences, 2008
- The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor κB legend with bone mineral density in older adults: the Rancho Bernardo StudyEuropean Journal of Endocrinology, 2007
- A cross-sectional study of bone turnover markers in healthy premenopausal womenBone, 2007
- Age‐related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian womenJournal of Clinical Laboratory Analysis, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell SurvivalJournal of Biological Chemistry, 1999
- Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with OsteoporosisJournal of Bone and Mineral Research, 1999